Rafal Surmacz

Dr. Rafal Surmacz

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JKJoanna Kwiatkowska
Joanna Kwiatkowska
MŻMałgorzata Żuk
Małgorzata Żuk
AMAnna Migdal
Anna Migdal
JKJacek Kusa
Jacek Kusa
ESElzbieta Skiba
Elzbieta Skiba
Grzegorz KopecGrzegorz Kopec
Grzegorz Kopec
We present the results from the pediatric arm of the Polish Registry of Pulmonary Hypertension. We prospectively enrolled all pulmonary arterial hypertension (PAH) patients, between the ages of 3 months and 18 years, who had been under the care of each PAH center in Poland between 1 March 2018 and 30 September 2018. The mean prevalence of PAH was 11.6 per million, and the estimated incidence rate was 2.4 per million/year, but it was geographically heterogeneous. Among 80 enrolled children (females, n = 40; 50%), 54 (67.5%) had PAH associated with congenital heart disease (CHD-PAH), 25 (31.25%) had idiopathic PAH (IPAH), and 1 (1.25%) had portopulmonary PAH. At the time of enrolment, 31% of the patients had significant impairment of physical capacity (WHO-FC III). The most frequent comorbidities included shortage of growth (n = 20; 25%), mental retardation (n = 32; 40%), hypothyroidism (n = 19; 23.8%) and Down syndrome (n = 24; 30%). The majority of children were treated with PAH-specific medications, but only half of them with double combination therapy, which improved after changing the reimbursement policy. The underrepresentation of PAH classes other than IPAH and CHD-PAH, and the geographically heterogeneous distribution of PAH prevalence, indicate the need for building awareness of PAH among pediatricians, while a frequent coexistence of PAH with other comorbidities calls for a multidisciplinary approach to the management of PAH children.

1 January 2006 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
MPMałgorztata Pawelec-Wojtalik
Małgorztata Pawelec-Wojtalik
MWMichal Wojtalik
Michal Wojtalik
WMWojciech Mrowczynski
Wojciech Mrowczynski
RSRafal Surmacz
Rafal Surmacz
SQShakeel Ahmed Quereshi
Shakeel Ahmed Quereshi
Objective: The aim of the retrospective study was to examine the changes in the left and right ventricular size as well as the systolic and diastolic function of the left ventricle after surgical and transcatheter treatment of atrial septal defects with Amplatzer atrial septal defect occluder (ASDO). Methods: Two groups of patients were examined using transthoracic cross-sectional echocardiography before and after the treatment of atrial septal defect: Group A – Amplatzer ASD occluder – 38 children and Group S treated surgically – 20 children. The following parameters were assessed: left and right ventricular end-diastolic diameter indexes, ejection fraction, mitral E wave to A wave velocity ratio, deceleration time (DCT), isovolumetric relaxation time (IVRT) and heart rate. Results: There was a significant decrease in right ventricular and an increase in left ventricular size in both groups during the follow-up observation. The long-term ECHO examination revealed smaller right ventricle (RV) (Group A: RVEDI=1.00 ± 0.20 vs Group S RVEDI: 1.18 ± 0.20 (p = 0.001)) and bigger left ventricle (Group A: LVEDI = 1.04 ± 0.08 vs Group S: LVEDI = 0.99 ± 0.07 (p = 0.022)) in Group A in comparison to Group S. Children undergoing operation had significantly shorter IVRT (Group A: IVRT = 50.00 ± 9.65 vs Group S: IVRT = 42.5 ± 8.95 (p = 0.02)) than patients after ASDO device application. Conclusions: (1) During the follow-up period, the diastolic function of the left ventricle is better in children with device closure of ASD compared with those patients treated surgically. (2) Postoperative changes of the left and right ventricular size indexes are more favourable in patients after the device closure of ASD compared with children undergoing the surgical procedure.

30 November 2005 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
PDF file
MWMichał Wojtalik
Michał Wojtalik
WMWojciech Mrówczyński
Wojciech Mrówczyński
JHJacek Henschke
Jacek Henschke
KWKrzysztof Wronecki
Krzysztof Wronecki
ASAldona Siwińska
Aldona Siwińska
RSRafal Surmacz
Rafal Surmacz

12 April 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JKJoanna Kwiatkowska
Joanna Kwiatkowska
JMJarosław Meyer-Szary
Jarosław Meyer-Szary
AMAnna Mazurek-Kula
Anna Mazurek-Kula
MŻMałgorzata Żuk
Małgorzata Żuk
AMAnna Migdal
Anna Migdal
Grzegorz KopecGrzegorz Kopec
Grzegorz Kopec
The COVID-19 pandemic has impacted healthcare systems worldwide. Little is known about the impact of the pandemic on medical and psycho-social aspects of children with rare diseases such as pulmonary arterial hypertension and their parents. The study is based on children registered in The Database of Pulmonary Hypertension in the Polish Population and a parent-reported survey deployed during the first 6 months of the pandemic. The questionnaire consisted of six question panels: demographic data, fear of COVID-19, General Anxiety Disorder-7 (GAD-7), social impact of pandemic, patients’ medical status, and alarming symptoms (appearance or exacerbation). Out of 80 children registered, we collected 58 responses (72.5% response rate). Responders (parents) were mostly female (n = 55; 94.8%) at a mean age of 40.6 ± 6.9 years. Patients (children) were both females (n = 32; 55%) and males with a mean age of 10.0 ± 5.1 years. Eleven (19%) children had symptoms of potential disease exacerbation. Eight parents (72.7%) decided for watchful waiting while others contacted their GPs or cardiologists (n = 6; 54.5%). Three children had to be hospitalized (27.3%). Most planned hospitalizations (27/48; 56.2%) and out-patient visits (20/35; 57.1%) were cancelled, delayed, or substituted by telehealth services. Among the participating parents, the study shows very high levels of anxiety (n = 20; 34.5%) and concern (n = 55; 94.8%) and the need for detailed information (52; 89.6%) regarding COVID-19 and medical service preparedness during the pandemic. The COVID-19 pandemic has influenced child healthcare and caused high levels of anxiety among parents.

1 December 2005
Verified
Journal Article
Closed access
MPMałgorzata Pawelec-Wojtalik
Małgorzata Pawelec-Wojtalik
MWMichał Wojtalik
Michał Wojtalik
WMWojciech Mrówczyński
Wojciech Mrówczyński
RSRafal Surmacz
Rafal Surmacz